Piperine promotes autophagy flux by P2RX4 activation in SNCA/α-synuclein-induced Parkinson disease model

References

• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8(6):329–339.
   PubMed Web of Science ®Google Scholar
• Breen KC, Drutyte G. Non-motor symptoms of Parkinson’s disease: the patient’s perspective. J Neural Transm. 2013;120(4):531–535.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm. 2015;122(10):1429–1440.
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol. 2017;16(6):478–488.
   PubMed Web of Science ®Google Scholar
• Braak H, Del TK, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211.
   PubMed Web of Science ®Google Scholar
• Fleming SM, Tetreault NA, Mulligan CK, et al. Olfactory deficits in mice overexpressing human wildtype -synuclein. Eur J Neurosci. 2008;28(2):247–256.
   PubMed Web of Science ®Google Scholar
• Chesselet M, Richter F, Zhu C, et al. Model of Parkinson’s Disease: the Thy1-aSyn (“Line 61”) Mice. Neurotherapeutics. 2012;9(2):297–314.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1–2):11–42.
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, McLean PJ, Unni VK. Alpha-synuclein’s degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease. Autophagy. 2012;8(2):281–283.
   PubMed Web of Science ®Google Scholar
• Jaishy B, Abel ED. Lipids, lysosomes, and autophagy. J Lipid Res. 2016;57(9):1619–1635.
   PubMed Web of Science ®Google Scholar
• Fu R, Deng Q, Zhang H, et al. A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3. Cell Death Dis. 2018;9(2):243.
   Web of Science ®Google Scholar
• Mauvezin C, Nagy P, Juhász G, et al. Autophagosome–lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun. 2015;6(1):7007.
   PubMed Web of Science ®Google Scholar
• Kim DK, Lim HS, Kawasaki I, et al. Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function. Autophagy. 2016;12(10):1849–1863.
   PubMed Web of Science ®Google Scholar
• Chen L, Xie Z, Turkson S, et al. 53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci. 2015;35(3):890–905.
   PubMed Web of Science ®Google Scholar
• Antonioli L, Blandizzi C, Fornai M, et al. P2X4 receptors, immunity, and sepsis. Curr Opin Pharmacol. 2019;47:65–74.
   PubMed Web of Science ®Google Scholar
• Murrell-Lagnado RD, Frick M. P2X4 and lysosome fusion. Curr Opin Pharmacol. 2019;47(4):126–132.
   PubMed Web of Science ®Google Scholar
• Huang P, Zou Y, Zhong XZ, et al. P2X4 forms functional ATP-activated cation channels on lysosomal membranes regulated by luminal pH. J Biol Chem. 2014;289(25):17658–17667.
   PubMed Web of Science ®Google Scholar
• Zhong XZ, Yang Y, Sun X, et al. Methods for monitoring Ca2+ and ion channels in the lysosome. Cell Calcium. 2017;64:20–28.
   PubMed Web of Science ®Google Scholar
• Savica R, Boeve BF, Mielke MM. When do α-synucleinopathies start? An epidemiological timeline. Jama Neurol. 2018;75(4):503.
   PubMed Web of Science ®Google Scholar
• Krishna MS, Joy B, Sundaresan A. Effect on oxidative stress, glucose uptake level and lipid droplet content by Apigenin 7, 4ʹ-dimethyl ether isolated from Piper longum L. J Food Sci Technol. 2015;52(6):3561–70.
   Web of Science ®Google Scholar
• Lu Y, Liu J, Li H, et al. Piperine ameliorates lipopolysaccharide-induced acute lung injury via modulating NF-κB signaling pathways. Inflammation. 2016;39(1):303–308.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu W, Lu Y, et al. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018;14(5):845–861.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen M, Wang X, et al. Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson’s disease model. Oncotarget. 2016;7(38):60823.
   PubMedGoogle Scholar
• Webb JL, Ravikumar B, Atkins J, et al. α-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem. 2003;278(27):25009–25013.
   PubMed Web of Science ®Google Scholar
• Rott R, Szargel R, Shani V, et al. SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation. Proc Nat Acad Sci. 2017;114(50):13176–13181.
   PubMed Web of Science ®Google Scholar
• Du T, Wang L, Duan C, et al. GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A. Autophagy. 2015;11(10):1803–1820.
   PubMed Web of Science ®Google Scholar
• Siddiqi FH, Menzies FM, Lopez A, et al. Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing. Nat Commun. 2019;10:1.
   PubMed Web of Science ®Google Scholar
• Dhuna K, Felgate M, Bidula SM, et al. Ginsenosides act as positive modulators of P2X4 receptors. Mol Pharmacol. 2019;95(2):210–221.
   PubMed Web of Science ®Google Scholar
• Abdelrahman A, Namasivayam V, Hinz S, et al. Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies. Biochem Pharmacol. 2017;125:41–54.
   PubMed Web of Science ®Google Scholar
• Vats S, Manjithaya R. A reversible autophagy inhibitor blocks autophagosome-lysosome fusion by preventing Stx17 loading onto autophagosomes. Mol Biol Cell. 2019;30(17):2283–2295.
   PubMed Web of Science ®Google Scholar
• Bi Y, Qu P, Wang Q, et al. Neuroprotective effects of alkaloids fromPiper longum in a MPTP-induced mouse model of Parkinson’s disease. Pharm Biol. 2015;53(10):1516–1524.
   PubMed Web of Science ®Google Scholar
• Shrivastava P, Vaibhav K, Tabassum R, et al. Anti-apoptotic and anti-inflam matory effect of piperine on 6-OHDA induced Parkinson’s rat model. J Nutr Bio chem. 2013;24(4):680–68 7.
   PubMed Web of Science ®Google Scholar
• Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17(9):660–688.
   PubMed Web of Science ®Google Scholar
• Chu Y, Dodiya H, Aebischer P, et al. Alterations in lysosomal and proteasomal markers in Parkinson’s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis. 2009;35(3):385–398.
   PubMed Web of Science ®Google Scholar
• Dehay B, Bove J, Rodriguez-Muela N, et al. Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci. 2010;30(37):12535–12544.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol. 2010;67(12):1464–1472.
   PubMedGoogle Scholar
• Bourdenx M, Bezard E, Dehay B. Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death. Front Neuroanat. 2014;8:83.
   PubMed Web of Science ®Google Scholar
• Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019;18(12):923–948.
   PubMed Web of Science ®Google Scholar
• Datta A, Chai YL, Tan JM, et al. An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias. Mol Brain. 2017;10(1):36.
   PubMed Web of Science ®Google Scholar
• Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease. Mol Brain. 2019;12(1):8.
   PubMed Web of Science ®Google Scholar
• Ping L, Duong DM, Yin L, et al. Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s disease. SCI Data. 2018;5(1):180036.
   Web of Science ®Google Scholar
• Nathan BP, Yost J, Litherland MT, et al. Olfactory function in apoE knockout mice. Behav Brain Res. 2004;150(1–2):1–7.
   PubMed Web of Science ®Google Scholar
• Lazarini F, Gabellec MM, Moigneu C, et al. Adult neurogenesis restores dopaminergic neuronal loss in the olfactory bulb. J Neurosci. 2014;34(43):14430–14442.
   PubMed Web of Science ®Google Scholar
• Höglinger GU, Alvarez-Fischer D, Arias-Carrión O, et al. A new dopaminergic nigro-olfactory projection. Acta Neuropathol. 2015;130(3):333–348.
   PubMed Web of Science ®Google Scholar
• Alkhlaif Y, Bagdas D, Jackson A, et al. Assessment of nicotine withdrawal-induced changes in sucrose preference in mice. Pharmacol Biochem Be. 2017;161:47–52.
   PubMed Web of Science ®Google Scholar
• Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc. 1957;46(3):208–209.
   PubMedGoogle Scholar
• Ogawa N, Hirose Y, Ohara S, et al. A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol. 1985;50(3):435.
   PubMedGoogle Scholar
• Tian H, Yongquan L, Liu J, et al. Leucine carboxyl methyltransferase downregulation and protein phosphatase methylesterase upregulation contribute toward the inhibition of protein phosphatase 2A by α-synuclein. Front Aging Neurosci. 2018;10:173.
   PubMed Web of Science ®Google Scholar